Literature DB >> 27718505

Optimization of techniques for multiple platform testing in small, precious samples such as human chorionic villus sampling.

Margareta D Pisarska1,2, Marzieh Akhlaghpour1, Bora Lee1, Gillian M Barlow1, Ning Xu3, Erica T Wang1,2, Aaron J Mackey4, Charles R Farber4, Stephen S Rich4, Jerome I Rotter5, Yii-der I Chen5, Mark O Goodarzi3, Seth Guller6, John Williams2,7.   

Abstract

BACKGROUND: Multiple testing to understand global changes in gene expression based on genetic and epigenetic modifications is evolving. Chorionic villi, obtained for prenatal testing, is limited, but can be used to understand ongoing human pregnancies. However, optimal storage, processing and utilization of CVS for multiple platform testing have not been established.
RESULTS: Leftover CVS samples were flash-frozen or preserved in RNAlater. Modifications to standard isolation kits were performed to isolate quality DNA and RNA from samples as small as 2-5 mg. RNAlater samples had significantly higher RNA yields and quality and were successfully used in microarray and RNA-sequencing (RNA-seq). RNA-seq libraries generated using 200 versus 800-ng RNA showed similar biological coefficients of variation. RNAlater samples had lower DNA yields and quality, which improved by heating the elution buffer to 70 °C. Purification of DNA was not necessary for bisulfite-conversion and genome-wide methylation profiling. CVS cells were propagated and continue to express genes found in freshly isolated chorionic villi.
CONCLUSIONS: CVS samples preserved in RNAlater are superior. Our optimized techniques provide specimens for genetic, epigenetic and gene expression studies from a single small sample which can be used to develop diagnostics and treatments using a systems biology approach in the prenatal period.
© 2016 John Wiley & Sons, Ltd. © 2016 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27718505      PMCID: PMC5142835          DOI: 10.1002/pd.4936

Source DB:  PubMed          Journal:  Prenat Diagn        ISSN: 0197-3851            Impact factor:   3.050


  46 in total

1.  Cytogenetic analysis of 1508 spontaneous abortions originating from south Slovakia.

Authors:  J Dejmek; J Vojtassák; J Malová
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  1992-09-23       Impact factor: 2.435

2.  Chorionic mosaicism: association with fetal loss but not with adverse perinatal outcome.

Authors:  R J Wapner; J L Simpson; M S Golbus; J M Zachary; D H Ledbetter; R J Desnick; S E Fowler; L G Jackson; H Lubs; R J Mahony
Journal:  Prenat Diagn       Date:  1992-05       Impact factor: 3.050

3.  Spontaneous abortion and confined chromosomal mosaicism.

Authors:  D K Kalousek; I J Barrett; A B Gärtner
Journal:  Hum Genet       Date:  1992-03       Impact factor: 4.132

Review 4.  Placental peptides as markers of gestational disease.

Authors:  Nigel M Page; C Fred Kemp; David J Butlin; Philip J Lowry
Journal:  Reproduction       Date:  2002-04       Impact factor: 3.906

5.  Lamellar body counts compared with traditional phospholipid analysis as an assay for evaluating fetal lung maturity.

Authors:  M G Neerhof; E I Haney; R K Silver; E R Ashwood; I S Lee; J J Piazze
Journal:  Obstet Gynecol       Date:  2001-02       Impact factor: 7.661

6.  Inhibition of human trophoblast invasiveness by high glucose concentrations.

Authors:  Louiza Belkacemi; Gendie E Lash; Shannyn K Macdonald-Goodfellow; Jason D Caldwell; Charles H Graham
Journal:  J Clin Endocrinol Metab       Date:  2005-05-10       Impact factor: 5.958

7.  Failure of physiologic transformation of the spiral arteries in the placental bed in preterm premature rupture of membranes.

Authors:  Yeon Mee Kim; Tinnakorn Chaiworapongsa; Ricardo Gomez; Emmanuel Bujold; Bo Hyun Yoon; Siegfried Rotmensch; Howard T Thaler; Roberto Romero
Journal:  Am J Obstet Gynecol       Date:  2002-11       Impact factor: 8.661

Review 8.  Cytokines, prostaglandins and parturition--a review.

Authors:  J A Keelan; M Blumenstein; R J A Helliwell; T A Sato; K W Marvin; M D Mitchell
Journal:  Placenta       Date:  2003-04       Impact factor: 3.481

Review 9.  Expression of imprinted genes in human preimplantation development.

Authors:  M Monk; A Salpekar
Journal:  Mol Cell Endocrinol       Date:  2001-10-22       Impact factor: 4.102

10.  Genomic imprinting and environmental disease susceptibility.

Authors:  R L Jirtle; M Sander; J C Barrett
Journal:  Environ Health Perspect       Date:  2000-03       Impact factor: 9.031

View more
  9 in total

1.  The identification of challenges in tissue collection for biomarker studies: the Q-CROC-03 neoadjuvant breast cancer translational trial experience.

Authors:  Adriana Aguilar-Mahecha; Josiane Lafleur; Manuela Pelmus; Carole Seguin; Cathy Lan; Federico Discepola; Bojan Kovacina; Rosa Christodoulopoulos; Ombretta Salvucci; Catalin Mihalcioiu; Josée-Anne Roy; André Robidoux; Elizabeth A Marcus; Gerald Batist; Mark Basik
Journal:  Mod Pathol       Date:  2017-07-28       Impact factor: 7.842

Review 2.  Hemochorial placentation: development, function, and adaptations.

Authors:  Michael J Soares; Kaela M Varberg; Khursheed Iqbal
Journal:  Biol Reprod       Date:  2018-07-01       Impact factor: 4.285

3.  Differences in First-Trimester Maternal Metabolomic Profiles in Pregnancies Conceived From Fertility Treatments.

Authors:  Tianyanxin Sun; Bora Lee; Jason Kinchen; Erica T Wang; Tania L Gonzalez; Jessica L Chan; Jerome I Rotter; Yii-Der Ida Chen; Kent Taylor; Mark O Goodarzi; Stephen S Rich; Charles R Farber; John Williams; Margareta D Pisarska
Journal:  J Clin Endocrinol Metab       Date:  2019-04-01       Impact factor: 5.958

4.  Up-regulation of microRNA-202-3p in first trimester placenta of pregnancies destined to develop severe preeclampsia, a pilot study.

Authors:  Krishna Singh; John Williams; Jordan Brown; Erica T Wang; Bora Lee; Tania L Gonzalez; Jinrui Cui; Mark O Goodarzi; Margareta D Pisarska
Journal:  Pregnancy Hypertens       Date:  2017-05-08       Impact factor: 2.899

5.  High-throughput miRNA sequencing of the human placenta: expression throughout gestation.

Authors:  Tania L Gonzalez; Laura E Eisman; Nikhil V Joshi; Amy E Flowers; Di Wu; Yizhou Wang; Chintda Santiskulvong; Jie Tang; Rae A Buttle; Erica Sauro; Ekaterina L Clark; Rosemarie DiPentino; Caroline A Jefferies; Jessica L Chan; Yayu Lin; Yazhen Zhu; Yalda Afshar; Hsian-Rong Tseng; Kent Taylor; John Williams; Margareta D Pisarska
Journal:  Epigenomics       Date:  2021-05-25       Impact factor: 4.778

6.  Sex differences in microRNA expression in first and third trimester human placenta†.

Authors:  Amy E Flowers; Tania L Gonzalez; Nikhil V Joshi; Laura E Eisman; Ekaterina L Clark; Rae A Buttle; Erica Sauro; Rosemarie DiPentino; Yayu Lin; Di Wu; Yizhou Wang; Chintda Santiskulvong; Jie Tang; Bora Lee; Tianyanxin Sun; Jessica L Chan; Erica T Wang; Caroline Jefferies; Kate Lawrenson; Yazhen Zhu; Yalda Afshar; Hsian-Rong Tseng; John Williams; Margareta D Pisarska
Journal:  Biol Reprod       Date:  2022-03-19       Impact factor: 4.161

7.  Sexually Dimorphic Crosstalk at the Maternal-Fetal Interface.

Authors:  Tianyanxin Sun; Tania L Gonzalez; Nan Deng; Rosemarie DiPentino; Ekaterina L Clark; Bora Lee; Jie Tang; Yizhou Wang; Barry R Stripp; Changfu Yao; Hsian-Rong Tseng; S Ananth Karumanchi; Alexander F Koeppel; Stephen D Turner; Charles R Farber; Stephen S Rich; Erica T Wang; John Williams; Margareta D Pisarska
Journal:  J Clin Endocrinol Metab       Date:  2020-12-01       Impact factor: 5.958

8.  Sex differences in the late first trimester human placenta transcriptome.

Authors:  Tania L Gonzalez; Tianyanxin Sun; Alexander F Koeppel; Bora Lee; Erica T Wang; Charles R Farber; Stephen S Rich; Lauren W Sundheimer; Rae A Buttle; Yii-Der Ida Chen; Jerome I Rotter; Stephen D Turner; John Williams; Mark O Goodarzi; Margareta D Pisarska
Journal:  Biol Sex Differ       Date:  2018-01-15       Impact factor: 5.027

Review 9.  Current approaches and developments in transcript profiling of the human placenta.

Authors:  Hannah E J Yong; Shiao-Yng Chan
Journal:  Hum Reprod Update       Date:  2020-11-01       Impact factor: 15.610

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.